rs1381532

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014290.3(TDRD7):​c.33A>G​(p.Leu11Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.493 in 1,613,556 control chromosomes in the GnomAD database, including 197,663 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 21774 hom., cov: 32)
Exomes 𝑓: 0.49 ( 175889 hom. )

Consequence

TDRD7
NM_014290.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.52

Publications

26 publications found
Variant links:
Genes affected
TDRD7 (HGNC:30831): (tudor domain containing 7) The protein encoded by this gene belongs to the Tudor family of proteins. This protein contains conserved Tudor domains and LOTUS domains. It is a component of RNA granules, which function in RNA processing. Mutations in this gene have been associated with cataract formation in mouse and human. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
TDRD7 Gene-Disease associations (from GenCC):
  • cataract 36
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 9-97428498-A-G is Benign according to our data. Variant chr9-97428498-A-G is described in ClinVar as Benign. ClinVar VariationId is 260382.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.52 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.606 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TDRD7NM_014290.3 linkc.33A>G p.Leu11Leu synonymous_variant Exon 2 of 17 ENST00000355295.5 NP_055105.2 Q8NHU6-1
TDRD7XM_047423111.1 linkc.33A>G p.Leu11Leu synonymous_variant Exon 2 of 17 XP_047279067.1
TDRD7XM_047423113.1 linkc.33A>G p.Leu11Leu synonymous_variant Exon 2 of 14 XP_047279069.1
TDRD7NM_001302884.2 linkc.-15-2435A>G intron_variant Intron 1 of 15 NP_001289813.1 Q8NHU6-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TDRD7ENST00000355295.5 linkc.33A>G p.Leu11Leu synonymous_variant Exon 2 of 17 1 NM_014290.3 ENSP00000347444.4 Q8NHU6-1

Frequencies

GnomAD3 genomes
AF:
0.531
AC:
80740
AN:
151930
Hom.:
21732
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.611
Gnomad AMI
AF:
0.464
Gnomad AMR
AF:
0.554
Gnomad ASJ
AF:
0.473
Gnomad EAS
AF:
0.562
Gnomad SAS
AF:
0.436
Gnomad FIN
AF:
0.495
Gnomad MID
AF:
0.418
Gnomad NFE
AF:
0.492
Gnomad OTH
AF:
0.523
GnomAD2 exomes
AF:
0.508
AC:
127526
AN:
251002
AF XY:
0.499
show subpopulations
Gnomad AFR exome
AF:
0.608
Gnomad AMR exome
AF:
0.582
Gnomad ASJ exome
AF:
0.477
Gnomad EAS exome
AF:
0.562
Gnomad FIN exome
AF:
0.486
Gnomad NFE exome
AF:
0.490
Gnomad OTH exome
AF:
0.487
GnomAD4 exome
AF:
0.489
AC:
714018
AN:
1461508
Hom.:
175889
Cov.:
59
AF XY:
0.486
AC XY:
353490
AN XY:
727076
show subpopulations
African (AFR)
AF:
0.608
AC:
20359
AN:
33462
American (AMR)
AF:
0.579
AC:
25865
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.473
AC:
12358
AN:
26124
East Asian (EAS)
AF:
0.531
AC:
21071
AN:
39696
South Asian (SAS)
AF:
0.438
AC:
37764
AN:
86254
European-Finnish (FIN)
AF:
0.482
AC:
25767
AN:
53406
Middle Eastern (MID)
AF:
0.405
AC:
2325
AN:
5744
European-Non Finnish (NFE)
AF:
0.485
AC:
538952
AN:
1111756
Other (OTH)
AF:
0.490
AC:
29557
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
21440
42880
64319
85759
107199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15856
31712
47568
63424
79280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.532
AC:
80834
AN:
152048
Hom.:
21774
Cov.:
32
AF XY:
0.532
AC XY:
39504
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.612
AC:
25378
AN:
41476
American (AMR)
AF:
0.555
AC:
8479
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.473
AC:
1638
AN:
3466
East Asian (EAS)
AF:
0.561
AC:
2897
AN:
5166
South Asian (SAS)
AF:
0.437
AC:
2103
AN:
4816
European-Finnish (FIN)
AF:
0.495
AC:
5228
AN:
10558
Middle Eastern (MID)
AF:
0.425
AC:
125
AN:
294
European-Non Finnish (NFE)
AF:
0.492
AC:
33461
AN:
67968
Other (OTH)
AF:
0.523
AC:
1103
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1937
3873
5810
7746
9683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
696
1392
2088
2784
3480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.501
Hom.:
25105
Bravo
AF:
0.540
Asia WGS
AF:
0.513
AC:
1784
AN:
3478
EpiCase
AF:
0.476
EpiControl
AF:
0.480

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cataract 36 Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.83
DANN
Benign
0.74
PhyloP100
-1.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1381532; hg19: chr9-100190780; COSMIC: COSV62428704; API